Status:
RECRUITING
Tailoring Treatment in Colorectal Cancer
Lead Sponsor:
University Hospital, Akershus
Collaborating Sponsors:
Oncosyne AS
Oslo University Hospital
Conditions:
Colorectal Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
In this study, the investigators will establish a reliable method and logistic pipeline for personalized drug testing ex vivo using fresh tumor samples from colorectal cancer (CRC) patients. With this...
Detailed Description
Primary hypothesis: Drug screening of patient-derived organoids is a feasible method to identify effective and ineffective therapies for personalized colorectal cancer treatment. Secondary hypothesis...
Eligibility Criteria
Inclusion
- Histologically confirmed colorectal cancer scheduled for curative surgery and standard clinical follow-up.
Exclusion
- \- Unable/unwilling to sign the informed consent form.
Key Trial Info
Start Date :
March 28 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05401318
Start Date
March 28 2022
End Date
January 1 2027
Last Update
August 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Akershus University Hospital
Lørenskog, Akershus, Norway, 1478